01 1DARMERICA, LLC
02 1Qingdao Biopeptek Co., Ltd.
01 2SLU-PP-332
01 2Blank
NDC Package Code : 73212-102
Start Marketing Date : 2025-01-01
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
NDC Package Code : 71052-078
Start Marketing Date : 2025-05-27
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
57
PharmaCompass offers a list of 4-Hydroxybenzoic Acid API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right 4-Hydroxybenzoic Acid manufacturer or 4-Hydroxybenzoic Acid supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred 4-Hydroxybenzoic Acid manufacturer or 4-Hydroxybenzoic Acid supplier.
PharmaCompass also assists you with knowing the 4-Hydroxybenzoic Acid API Price utilized in the formulation of products. 4-Hydroxybenzoic Acid API Price is not always fixed or binding as the 4-Hydroxybenzoic Acid Price is obtained through a variety of data sources. The 4-Hydroxybenzoic Acid Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Tox21_202342 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tox21_202342, including repackagers and relabelers. The FDA regulates Tox21_202342 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tox21_202342 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Tox21_202342 supplier is an individual or a company that provides Tox21_202342 active pharmaceutical ingredient (API) or Tox21_202342 finished formulations upon request. The Tox21_202342 suppliers may include Tox21_202342 API manufacturers, exporters, distributors and traders.
click here to find a list of Tox21_202342 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Tox21_202342 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Tox21_202342 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Tox21_202342 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Tox21_202342 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Tox21_202342 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Tox21_202342 suppliers with NDC on PharmaCompass.
